ARA-290, also known as Cibinetide, is a synthetic research peptide derived from the three-dimensional structure of erythropoietin, a naturally occurring signaling protein involved in cellular protection and physiological responses to stress. Unlike erythropoietin’s traditional association with red blood cell production, ARA-290 was specifically engineered to investigate tissue-protective signaling without stimulating erythropoiesis.

Research investigations have focused on ARA-290’s interaction with the innate repair receptor, a signaling complex formed by the erythropoietin receptor and the beta-common receptor CD131. This receptor is associated with the body’s response to inflammation, cellular stress, and tissue injury. Scientists continue to examine how activation of this pathway may influence inflammatory regulation, immune-cell activity, cellular survival, nerve-fiber integrity, and tissue-repair processes within laboratory models.

Studies involving ARA-290 have explored neurological signaling, neuroinflammation, peripheral nerve function, neuropathic pathways, small-fiber nerve density, microglial activity, metabolic physiology, and cellular recovery following injury or inflammatory stress. Researchers have also investigated its activity in experimental models related to diabetic neuropathy, small-fiber neuropathy, inflammatory tissue injury, sensory nerve dysfunction, and metabolic regulation.

ARA-290 remains an active area of research in studies involving neurological biology, inflammatory signaling, immune-system regulation, tissue protection, nerve-fiber repair, cellular survival, and peptide-based regenerative pathways.

Blackburn Peptides supplies ARA-290 as a research-grade material intended exclusively for laboratory and scientific applications.

This product is not intended for human or veterinary use.